Westmount Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Westmount Partners's AMGN Position: Q2 2026 in Review
Westmount Partners reduced its Amgen (AMGN) stake by 1.6% in Q2 2026, selling an estimated $20.9K and leaving 3,735 shares worth $1.35M. The position accounts for 0.3% of the portfolio, ranked #75.
Westmount Partners first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.38M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Westmount Partners held 3,735 shares of Amgen worth $1.35M as of Q2 2026.
- Westmount Partners sold 61 Amgen shares in Q2 2026, an estimated $20.9K.
- Amgen made up 0.3% of Westmount Partners's portfolio in Q2 2026, its #75 holding.
- Westmount Partners first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
- Westmount Partners's Amgen position peaked at $1.38M in Q3 2024.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Westmount Partners's 13F filing for Q2 2026, filed 7 Jul 2026.